6-K 1 lloy201308216k.htm SALE OF HEIDELBERGER LEBEN lloy201308216k.htm
 
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.20549
 
 
FORM 6-K
 
 
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934
 
 
21 August 2013

LLOYDS BANKING GROUP plc

(Translation of registrant's name into English)
 
5th Floor
25 Gresham Street
London
EC2V 7HN
United Kingdom
 
 
(Address of principal executive offices)
 
 
 
Indicate by check mark whether the registrant files or will file annual reports
under cover Form 20-F or Form 40-F.
 
Form 20-F..X..     Form 40-F.....
 
 
Indicate by check mark whether the registrant by furnishing the information
contained in this Form is also thereby furnishing the information to the
Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
 
Yes .....      No ..X..
 
If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule
12g3-2(b): 82- ________
 
 
Index to Exhibits

 

 
21 August 2013
 
LLOYDS BANKING GROUP ANNOUNCES THE SALE OF HEIDELBERGER LEBEN
 
Lloyds Banking Group plc ("the Group") announces that it has signed an agreement to sell its German life insurance business Heidelberger Lebensversicherung AG ("Heidelberger Leben" or "the business") to a joint venture company owned by Cinven Partners LLP and Hannover Rück SE ("the buyer"), for a cash consideration of around €300 million, or approximately £250 million at current exchange rates.
 
Heidelberger Leben is a specialist provider of unit-linked pension, investment and life assurance products in Germany. The senior management employed by Heidelberger Leben will move with the business on completion of the sale. The business will continue to service the Group's policies in Germany and Austria written under the Clerical Medical brand, under a long-term administration agreement.
 
The gross assets subject to the transaction are £7.2 billion, which are predominantly policyholder assets. In the year to 31 December 2012 the business reported a statutory loss of £38 million. The sale of Heidelberger Leben is expected to lead to a loss on disposal of approximately £330 million in the Group's accounts but, combined with the sale of other assets, is currently expected to result in a benefit to the Group's common equity tier 1 capital of approximately £0.4 billion upon completion, equivalent to an approximate benefit of 13 basis points on a pro forma fully loaded CRD IV basis. The cash proceeds from the sale will be used for general corporate purposes.
 
The sale is in line with the Group's strategy of rationalising its international presence and ensuring value for shareholders.
 
The transaction is subject to regulatory approval and is expected to complete in early 2014.
- END -

For further information:
 
Investor Relations
Charles King                                                                                  +44 (0) 20 7356 3537
Investor Relations Director
Email: charles.king@finance.lloydsbanking.com
 
Corporate Affairs
Ross Keany                                                                                   +44 (0) 131 655 5354
Head of Media Relations, Insurance
Email: ross.keany@lloydsbanking.com
 
 
FORWARD LOOKING STATEMENTS
 
This announcement contains forward looking statements with respect to the business, strategy and plans of the Lloyds Banking Group, its current goals and expectations relating to its future financial condition and performance. Statements that are not historical facts, including statements about the Group or the Group's management's beliefs and expectations, are forward looking statements. By their nature, forward looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will or may occur in the future. The Group's actual future business, strategy, plans and/or results may differ materially from those expressed or implied in these forward looking statements as a result of a variety of risks, uncertainties and other factors, including, but not limited to, UK domestic and global economic and business conditions; the ability to derive cost savings and other benefits, including as a result of the Group's Simplification programme; the ability to access sufficient funding to meet the Group's liquidity needs; changes to the Group's credit ratings; risks concerning borrower or counterparty credit quality; instability in the global financial markets, including Eurozone instability and the impact of any sovereign credit rating downgrade or other sovereign financial issues; market-related risks including, but not limited to, changes in interest rates and exchange rates; changing demographic and market-related trends; changes in customer preferences; changes to laws, regulation, accounting standards or taxation, including changes to regulatory capital or liquidity requirements; the policies and actions of governmental or regulatory authorities in the UK, the European Union, or jurisdictions outside the UK in which the Group operates, including other European countries and the US; the implementation of the draft EU crisis management framework directive and banking reform following the recommendations made by the Independent Commission on Banking; the ability to attract and retain senior management and other employees; requirements or limitations imposed on the Group as a result of HM Treasury's investment in the Group; the ability to complete satisfactorily the disposal of certain assets as part of the Group's EC state aid obligations; the extent of any future impairment charges or write-downs caused by depressed asset valuations, market disruptions and illiquid markets; the effects of competition and the actions of competitors, including non-bank financial services and lending companies; exposure to regulatory scrutiny, legal proceedings, regulatory investigations or complaints, and other factors. Please refer to the latest Annual Report on Form 20-F filed with the US Securities and Exchange Commission for a discussion of certain factors together with examples of forward looking statements. The forward looking statements contained in this announcement are made as at the date of this announcement, and the Group undertakes no obligation to update any of its forward looking statements.
 
 
 
 
 
 
Signatures
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
                                                                                                                                                LLOYDS BANKING GROUP plc
                                                                                                                                                (Registrant)
 
 
 
                                                                                                                                                 By: Charles King
                                                                                                                                                 Name: Charles King
 
                                     Title:  Investor Relations Director
                                                                                      
                                           
 
 
 
 
 
                                                                                                                                                                                         
Date: 21 August 2013